Modification of the Properties of Extracellular Matrix of Senescent Mesenchymal Stem Cells.
cell senescence
endothelial cells
extracellular matrix
multipotent mesenchymal stem cells
Journal
Bulletin of experimental biology and medicine
ISSN: 1573-8221
Titre abrégé: Bull Exp Biol Med
Pays: United States
ID NLM: 0372557
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
04
04
2023
medline:
9
10
2023
pubmed:
29
9
2023
entrez:
28
9
2023
Statut:
ppublish
Résumé
Cell senescence leads to changes in the secretory activity of mesenchymal stem cells (MSC), including proteins of extracellular matrix (ECM). Here we studied the regulatory properties of ECM of senescent MSC in a model with endothelial cells (EC). EC were seeded onto a decellularized extracellular matrix of senescent MSC. Changes in cell morphology and a decrease in cell growth were observed. In addition, increased production of inflammatory chemokines MCP-1 and GROα and reduced synthesis of proangiogenic growth factor FGF-2 were revealed. Analysis of ECM showed quantitative and qualitative changes, including fibronectin layer morphology, total protein content, and concentration of deposited growth factors such as VEGF. Thus, our work demonstrates that senescence of MSC can lead to modification of the effects of their ECM on EC activity.
Identifiants
pubmed: 37770790
doi: 10.1007/s10517-023-05905-z
pii: 10.1007/s10517-023-05905-z
doi:
Substances chimiques
Intercellular Signaling Peptides and Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
569-575Informations de copyright
© 2023. Springer Science+Business Media, LLC, part of Springer Nature.
Références
Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen. Med. 2019;4:22. https://doi.org/10.1038/s41536-019-0083-6
doi: 10.1038/s41536-019-0083-6
pubmed: 31815001
pmcid: 6889290
Kehl D, Generali M, Mallone A, Heller M, Uldry AC, Cheng P, Gantenbein B, Hoerstrup SP, Weber B. Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential. NPJ Regen. Med. 2019;4:8. https://doi.org/10.1038/s41536-019-0070-y
doi: 10.1038/s41536-019-0070-y
pubmed: 31016031
pmcid: 6467904
Turinetto V, Vitale E, Giachino C. Senescence in human mesenchymal stem cells: functional changes and implications in stem cell-based therapy. Int. J. Mol. Sci. 2016;17(7):1164. https://doi.org/10.3390/ijms17071164
doi: 10.3390/ijms17071164
pubmed: 27447618
pmcid: 4964536
Lunyak VV, Amaro-Ortiz A, Gaur M. Mesenchymal stem cells secretory responses: senescence messaging secretome and immunomodulation perspective. Front. Genet. 2017;8:220. https://doi.org/10.3389/fgene.2017.00220
doi: 10.3389/fgene.2017.00220
pubmed: 29312442
pmcid: 5742268
Ratushnyy A, Ezdakova M, Buravkova L. Secretome of senescent adipose-derived mesenchymal stem cells negatively regulates angiogenesis. Int. J. Mol. Sci. 2020;21(5):1802. https://doi.org/10.3390/ijms21051802
doi: 10.3390/ijms21051802
pubmed: 32151085
pmcid: 7084202
Ratushnyy AY, Buravkova LB. Cell senescence and mesenchymal stromal cells. Hum. Physiol. 2020;46(1):85-93. https://doi.org/10.1134/S0362119720010132
doi: 10.1134/S0362119720010132
Ghosh D, Mejia Pena C, Quach N, Xuan B, Lee AH, Dawson MR. Senescent mesenchymal stem cells remodel extracellular matrix driving breast cancer cells to a more-invasive phenotype. J. Cell Sci. 2020;133(2):jcs232470. https://doi.org/10.1242/jcs.232470
Bertolo A, Baur M, Guerrero J, Pötzel T, Stoyanov J. Autofluorescence is a reliable in vitro marker of cellular senescence in human mesenchymal stromal cells. Sci. Rep. 2019;9(1):2074. https://doi.org/10.1038/s41598-019-38546-2
doi: 10.1038/s41598-019-38546-2
pubmed: 30765770
pmcid: 6376004
Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends Cell Biol. 2018;28(6):436-453. https://doi.org/10.1016/j.tcb.2018.02.001
doi: 10.1016/j.tcb.2018.02.001
pubmed: 29477613
Frescas D, Roux CM, Aygun-Sunar S, Gleiberman AS, Krasnov P, Kurnasov OV, Strom E, Virtuoso LP, Wrobel M, Osterman AL, Antoch MP, Mett V, Chernova OB, Gudkov AV. Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody. Proc. Natl Acad. Sci. USA. 2017;114(9):E1668-E1677. https://doi.org/10.1073/pnas.1614661114
doi: 10.1073/pnas.1614661114
pubmed: 28193858
pmcid: 5338544
Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 2005;120(4):513-522. https://doi.org/10.1016/j.cell.2005.02.003
doi: 10.1016/j.cell.2005.02.003
pubmed: 15734683
Mavrogonatou E, Pratsinis H, Papadopoulou A, Karamanos NK, Kletsas D. Extracellular matrix alterations in senescent cells and their significance in tissue homeostasis. Matrix Biol. 2019;75-76:27-42. https://doi.org/10.1016/j.matbio.2017.10.004
doi: 10.1016/j.matbio.2017.10.004
pubmed: 29066153
Selman M, Pardo A. From pulmonary fibrosis to progressive pulmonary fibrosis: a lethal pathobiological jump. Am. J. Physiol. Lung Cell. Mol. Physiol. 2021;321(3):L600-L607. https://doi.org/10.1152/ajplung.00310.2021
Bauer AL, Jackson TL, Jiang Y. Topography of extracellular matrix mediates vascular morphogenesis and migration speeds in angiogenesis. PLoS Comput. Biol. 2009;5(7):e1000445. https://doi.org/10.1371/journal.pcbi.1000445
doi: 10.1371/journal.pcbi.1000445
pubmed: 19629173
pmcid: 2709079
Shibuya M. Vascular Endothelial Growth Factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2011;2(12):1097-1105. https://doi.org/10.1177/1947601911423031
doi: 10.1177/1947601911423031
pubmed: 22866201
pmcid: 3411125
Claesson-Welsh L, Welsh M. VEGFA and tumour angiogenesis. J. Intern. Med. 2013;273(2):114-127. https://doi.org/10.1111/joim.12019
doi: 10.1111/joim.12019
pubmed: 23216836
Liu L, Ratner BD, Sage EH, Jiang S. Endothelial cell migration on surface-density gradients of fibronectin, VEGF, or both proteins. Langmuir. 2007;23(22):11 168-11 173. https://doi.org/10.1021/la701435x
Claffey KP, Abrams K, Shih SC, Brown LF, Mullen A, Keough M. Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis. Lab. Invest. 2001;81(1):61-75. https://doi.org/10.1038/labinvest.3780212
doi: 10.1038/labinvest.3780212
pubmed: 11204275
Ponticos M. Connective tissue growth factor (CCN2) in blood vessels. Vascul. Pharmacol. 2013;58(3):189-193. https://doi.org/10.1016/j.vph.2013.01.004
doi: 10.1016/j.vph.2013.01.004
pubmed: 23380714
Ungvari Z, Valcarcel-Ares MN, Tarantini S, Yabluchanskiy A, Fülöp GA, Kiss T, Csiszar A. Connective tissue growth factor (CTGF) in age-related vascular pathologies. Geroscience. 2017;39(5-6):491-498. https://doi.org/10.1007/s11357-017-9995-5
doi: 10.1007/s11357-017-9995-5
pubmed: 28875415
pmcid: 5745206